Improved Eye Plaque Brachytherapy Dosimetry Using Monte Carlo Methods

References

• “Cancer Facts & Figures 2010,” American Cancer Society (2010).
   Google Scholar
• S. NAG, J. M. QUIVEY, J. D. EARLE, D. FOLLOWILL, J. FONTANESI, and P. T. FINGER, “The American Brachytherapy Society Recommendations for Brachytherapy of Uveal Melanomas,” Int. J. Radiat. Oncol. Biol. Phys., 56, 544 (2003).
   PubMed Web of Science ®Google Scholar
• R. NATH, L. L. ANDERSON, G. LUXTON, K. A. WEAVER, J. F. WILLIAMSON, and A. S. MEIGOONI, “Dosimetry of Interstitial Brachytherapy Sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43,” Med. Phys., 22, 209 (1995).
   PubMed Web of Science ®Google Scholar
• M. J. RIVARD, B. M. COURSEY, L. A. DEWERD, W. F. HANSON, M. S. HUQ, G. S. IBBOTT, M. G. MITCH, R. NATH, and J. F. WILLIAMSON, “Update ofAAPMTask Group No. 43 Report: A Revised AAPM Protocol for Brachytherapy Dose Calculations,” Med. Phys., 31, 633 (2004).
   PubMed Web of Science ®Google Scholar
• S.-T. CHIU-TSAO, K. O’BRIEN, R. SANNA, H.-S. TSAO, C. VIALOTTI, Y.-S. CHANG, M. ROTMAN, and S. PACKER, “Monte Carlo Dosimetry for 125I and 60Co in Eye Plaque Therapy,” Med. Phys., 13, 678 (1986).
   Web of Science ®Google Scholar
• S.-T. CHIU-TSAO, L. L. ANDERSON, K. O’BRIEN, L. STABILE, and J. C. LIU, “Dosimetry for 125I Seed (Model 6711) in Eye Plaques,” Med. Phys., 20, 383 (1993).
   Web of Science ®Google Scholar
• J. CYGLER, J. SZANTO, M. SOUBRA, and D. W. O. ROGERS, “Effects of Gold and Silver Backings on the Dose Rate Around an 125I Seed,” Med. Phys., 17, 172 (1990).
   Web of Science ®Google Scholar
• K. WEAVER, “The Dosimetry of 125I Seed Eye Plaques,” Med. Phys., 13, 78 (1986).
   Web of Science ®Google Scholar
• G. LUXTON, M. A. ASTRAHAN, and Z. PETROVICH, “Backscatter Measurements from a Single Seed of 125I for Ophthalmic Plaque Dosimetry,” Med. Phys., 15, 397 (1988).
   Web of Science ®Google Scholar
• A. L. KRINTZ, W. F. HANSON, G. S. IBBOTT, and D. S. FOLLOWILL, “A Reanalysis of the Collaborative Ocular Melanoma Study Medium Tumor Trial Eye Plaque Dosimetry,” Int. J. Radiat. Oncol. Biol. Phys., 56, 889 (2003).
   Web of Science ®Google Scholar
• M. E. NAPOLITANO, K. K. MILLAGE, J. P. SEITZ, R. A. HEARN, and J. J. RODGERS, “Comparison of 103Pd and 125I Dose to Eye Structures During Treatment of Ocular Tumor or Age Related Macular Degeneration,” Med. Phys., 31, 1871 (2004).
   Web of Science ®Google Scholar
• M. E. NAPOLITANO, Personal Communications (Apr. and June 2010).
   Google Scholar
• C. S. MELHUS and M. J. RIVARD, “COMS Eye Plaque Brachytherapy Dosimetry Simulations for 103Pd, 125I, and 131Cs,” Med. Phys., 35, 3364 (2008).
   Web of Science ®Google Scholar
• R. M. THOMSON, R. E. P. TAYLOR, and D. W. O. ROGERS, “Monte Carlo Dosimetry for 125I and 103Pd Eye Plaque Brachytherapy,” Med. Phys., 36, 5530 (2008).
   Google Scholar
• R. M. THOMSON and D. W. O. ROGERS, “Monte Carlo Dosimetry for 125I and 103Pd Eye Plaque Brachytherapy with Various Seed Models,” Med. Phys., 37, 368 (2010).
   Web of Science ®Google Scholar
• D. GRANERO, J. PÉREZ-CALATAYUD, F. BALLESTER, E. CASAL, and J. M. DE FRUTOS, “Dosimetric Study of the 15 mm ROPES Eye Plaque,” Med. Phys., 31, 3330 (2004).
   Web of Science ®Google Scholar
• A. M. OWRANGI, J. JEZIORANSKI, I. YEUNG, H. KELLER, A. BEIKI-ARDAKANI, and R. CLARKSON, “Brachytherapy Dosimetry Simulation of Eye Physics Slotted Plaque: A Monte Carlo Study,” Brachytherapy, 8, 131 (2009).
   Google Scholar
• M. A. ASTRAHAN, “Improved Treatment Planning for COMS Eye Plaques,” Int. J. Radiat. Oncol. Biol. Phys., 61, 1227 (2005).
   PubMed Web of Science ®Google Scholar
• M. J. RIVARD, C. S. MELHUS, D. GRANERO, J. PÉREZCALATAYUD, and F. BALLESTER, “An Approach to Using Conventional Brachytherapy Software for Clinical Treatment Planning of Complex, Monte Carlo-Based Brachytherapy Dose Distributions,” Med. Phys., 36, 1968 (2009).
   Web of Science ®Google Scholar
• P. T. FINGER, K. J. CHIN, and G. DUVALL, “Palladium-103 Ophthalmic Plaque Radiation Therapy for Choroidal Melanoma: 400 Treated Patients,” Ophthalmology, 116, 790 (2009).
   PubMed Web of Science ®Google Scholar
• R. E. P. TAYLOR, G. YEGIN, and D. W. O. ROGERS, “Benchmarking BrachyDose:Voxel Based EGSnrc Monte Carlo Calculations of TG-43 Dosimetry Parameters,” Med. Phys., 34, 445 (2007).
   Web of Science ®Google Scholar
• “MCNP—A General Monte Carlo N-Particle Transport Code, Version 5,” X-5 MONTE CARLO TEAM, Los Alamos National Laboratory (2003).
   Google Scholar
• J. H. HUBBELL and S. M. SELTZER, “Tables of X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients (version 1.4),” National Institute of Standards and Technology; http://www.nist.gov/physlab/data/xraycoef/index.cfm (current as of December 17, 2010).
   Google Scholar
• M. A. ASTRAHAN, A. SZECHTER, and P. T. FINGER, “Design and Dosimetric Considerations of a Modified COMS Plaque: The Reusable ‘Seed-Guide’ Insert,” Med. Phys., 32, 2706 (2005).
   Web of Science ®Google Scholar
• M. J. RIVARD, W. M. BUTLER, P. M. DEVLIN, J. K. HAYES, R. A. HEARN, E. P. LIEF, A. S. MEIGOONI, G. S. MERRICK, and J. F. WILLIAMSON, “American Brachytherapy Society Recommends No Change for Prostate Permanent Implant Dose Prescriptions Using Iodine-125 or Palladium-103,” Brachytherapy, 6, 34 (2007).
   Web of Science ®Google Scholar
• K. ZOURARI, E. PANTELIS, A. MOUTSATSOS, L. PETROKOKKINOS, P. KARAISKOS, L. SAKELLIOU, E. GEORGIOU, and P. PAPAGIANNIS, “Dosimetric Accuracy of a Deterministic Radiation Transport Based 192Ir Brachytherapy Treatment Planning System. Part I: Single Sources and Bounded Homogeneous Geometries,” Med. Phys., 37, 649 (2010).
   Web of Science ®Google Scholar